First Amended Combined Liquidation Plan and Disclosure Statement Filed by Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc, along with its affiliate, filed an amended combined plan of liquidation and disclosure statement in the US Bankruptcy Court on December 21, 2022. As per the plan filed, there is no change in treatment of any claim class or source of funding. Clarus Therapeutics Holdings, Inc, along with its affiliate, filed solicitation version of amended combined plan of liquidation and disclosure statement in the US Bankruptcy Court on December 21, 2022.

As per the plan filed, there is no change in treatment of any claim class or source of funding.